Industry raised a lot of concerns about burden in its comments last month on FDA’s Aug. 24 draft quality metrics guidance document.
The agency’s estimated burden of reporting quality metrics under the program it had proposed was too low, all sectors of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?